List view / Grid view
14 June 2016 | By Victoria White, Digital Content Producer
Merck has announced results from two Phase III studies evaluating MK-1293 for the treatment of people with type 1 and type 2 diabetes...
14 June 2016 | By Victoria White, Digital Content Producer
The gang imported over 1.2 million unlicensed erectile dysfunction tablets and over 141,000 other illegal medicines including diazepam worth over £3.5 million...
Yusen Logistics has significantly strengthened its logistics presence in Duisburg; acquiring a new warehouse and expanding its storage capacity by 8,700 m². The total storage capacity of the multi-warehouse site is now 62,000 m².
13 June 2016 | By Victoria White, Digital Content Producer
Results showed improvement over chemotherapy on a number of measures including complete haematologic remission and progression-free survival...
13 June 2016 | By Victoria White, Digital Content Producer
A post-hoc analysis of the Phase III ASPIRE study highlighted the benefit of continued treatment with Kyprolis, lenalidomide and dexamethasone (KRd)...
13 June 2016 | By Victoria White, Digital Content Producer
New data for Jardiance (empagliflozin) show that reduced risk for cardiovascular (CV) death was consistent across age groups in adults with type 2 diabetes...
Results from Sanofi’s Phase III LixiLan-O and LixiLan-L clinical trials have been presented at the American Diabetes Association 76th Scientific Sessions.
13 June 2016 | By Victoria White, Digital Content Producer
Researchers have developed the world's first safe and effective vaccine against toxic shock syndrome and successfully tested it in a Phase I trial...
Lilly has announced new findings from separate studies of Trulicity (dulaglutide) and Tradjenta (linagliptin) at the American Diabetes Association 76th Scientific Sessions.
13 June 2016 | By Victoria White, Digital Content Producer
Novo Nordisk presented new findings from separate studies of Tresiba and semaglutide at the American Diabetes Association 76th Scientific Sessions...
10 June 2016 | By Victoria White, Digital Content Producer
Merck, known as MSD outside the US and Canada, has announced that it is is to acquire Afferent Pharmaceuticals...
10 June 2016 | By Victoria White, Digital Content Producer
Amgen's Blincyto (blinatumomab) demonstrated an almost two-times increase in median overall survival compared to standard of care...
10 June 2016 | By Victoria White, Digital Content Producer
A study shows that completely wiping out the immune system and then regenerating a new one can eliminate all signs of damaging brain inflammation in MS...
10 June 2016 | By CPhI
Key growth drivers for the MENA region were forecasted at CPhI Istanbul, with outsourcing, vaccine development and biotechnology emerging as major trends...
10 June 2016 | By Victoria White, Digital Content Producer
A study presented at EULAR showed that when antibodies develop in response to the infliximab, they also cross-react with the biosimilar of infliximab...
